Amoy Diagnostics Co (SZSE:300685) EBIT per Share : ¥0.77 (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Amoy Diagnostics Co EBIT per Share?

Amoy Diagnostics Co's EBIT per Share for the three months ended in Mar. 2024 was ¥0.18. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.77.

During the past 12 months, the average EBIT per Share Growth Rate of Amoy Diagnostics Co was 63.40% per year. During the past 3 years, the average EBIT per Share Growth Rate was 11.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was 8.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Amoy Diagnostics Co's EBIT per Share or its related term are showing as below:

SZSE:300685' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -10.6 Med: 20.85 Max: 78.2
Current: 11.2

During the past 12 years, the highest 3-Year average EBIT per Share Growth Rate of Amoy Diagnostics Co was 78.20% per year. The lowest was -10.60% per year. And the median was 20.85% per year.

SZSE:300685's 3-Year EBIT Growth Rate is ranked better than
66.48% of 176 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.7 vs SZSE:300685: 11.20

Amoy Diagnostics Co's EBIT for the three months ended in Mar. 2024 was ¥74 Mil.

Amoy Diagnostics Co EBIT per Share Historical Data

The historical data trend for Amoy Diagnostics Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amoy Diagnostics Co EBIT per Share Chart

Amoy Diagnostics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.62

0.50

0.63

0.73

0.75

Amoy Diagnostics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															0.16	0.21	0.13	0.25	0.18

Amoy Diagnostics Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Amoy Diagnostics Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	296.052	/	396.189
=	0.75

Amoy Diagnostics Co's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	73.873	/	401.244
=	0.18

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.77

Amoy Diagnostics Co (SZSE:300685) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Amoy Diagnostics Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Amoy Diagnostics Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Amoy Diagnostics Co (SZSE:300685) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Amoy Diagnostics Co Ltd (SZSE:300685) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

39 Dingshan Road, Haicang District, Xiamen, CHN, 361027

Website

http://www.amoydx.com

Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnostics for oncology precision medicine. It provides diagnostic products and services for medicine development and clinical oncology practice. The company's products include gene mutation, nucleic acid extraction, and molecular diagnostic kits comprising EGFR, RAS, ALK, BRAF, PIK3CA, and ROS1 testing kits.

Executives

Ruan Li	Directors, executives
Zheng Hui Bin	Directors, executives
Chen Ying	Directors, executives
Luo Jie Min	Executives
Zhu Guan Shan	Directors, executives
Yang Shou Qian	Securities Affairs Representative
Zhou Wen Gang	Executives
Zhou Xue Lin	Independent director
Hu Xu Bo	Director

Amoy Diagnostics Co (SZSE:300685) Headlines

No Headlines